Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL/6 mice

Neuroscience Letters

Volumn 401, Issue 1-2, 2006, Pages 183-187

  Ohashi, Satoshi ^a   Mori, Atsushi ^a   Kurihara, Naoki ^a   Mitsumoto, Yasuhide ^b   Nakai, Masami ^a  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Aging; Dopaminergic degeneration; Motor dysfunction; MPTP; Parkinson's disease; Tail suspension test

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; NEUROTOXIN;

AGE DISTRIBUTION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE SEVERITY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; INTOXICATION; MALE; MORTALITY; MOTOR DYSFUNCTION; MOUSE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; AGE FACTORS; AGING; ANIMALS; BRAIN; CELL DEATH; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOPAMINE; DYSKINESIA, DRUG-INDUCED; MALE; MICE; MICE, INBRED C57BL; NERVE DEGENERATION; NEURONS; PARKINSONIAN DISORDERS; SUBSTANTIA NIGRA;

EID: 33646431738     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.03.017     Document Type: Article

References (25)

1. Ara J., Przedborski S., Naini A.B., Jackson-Lewis V., Trifiletti R.R., Horwitz J., and Ischiropoulos H. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 7659-7663
2. Ballard P.A., Tetrud J.W., and Langston J.W. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology 35 (1985) 949-956
3. Ballok D.A., Millward J.M., and Sakic B. Neurodegeneration in autoimmune MRL-lpr mice as revealed by Fluoro Jade B staining. Brain Res. 964 (2003) 200-210
4. Betarbet R., Sherer T.B., and Greenamyre J.T. Animal models of Parkinson's disease. Bioessays 24 (2002) 308-318
5. Bowyer J.F., Peterson S.L., Rountree R.L., Tor-Agbidye J., and Wang G.J. Neuronal degeneration in rat forebrain resulting from d-amphetamine-induced convulsions is dependent on seizure severity and age. Brain Res. 809 (1998) 77-90
6. Burns R.S., Chiueh C.C., Markey S.P., Ebert M.H., Jacobowitz D.M., and Kopin I.J. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 4546-4550
7. Date I., Felten D.L., and Felten S.Y. Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis. Brain Res. 519 (1990) 266-276
8. Dauer W., and Przedborski S. Parkinson's disease: mechanisms and models. Neuron 39 (2003) 889-909
9. Giulivi C., and Cadenas E. The role of mitochondrial glutathione in DNA base oxidation. Biochim. Biophys. Acta 1366 (1998) 265-274
10. Gupta M., Gupta B.K., Thomas R., Bruemmer V., Sladek Jr. J.R., and Felten D.L. Aged mice are more sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment than young adults. Neurosci. Lett. 70 (1986) 326-331
11. Heikkila R.E., Hess A., and Duvoisin R.C. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science 224 (1984) 1451-1453
12. Hof P.R., Young W.G., Bloom F.E., Belichenko P.V., and Celio M.R. Comparative Cytoarchitectonic Atlas of the C57BL/6 and 129/Sv Mouse Brains (2000), Elsevier Science B.V.
13. Hopkins K.J., Wang G., and Schmued L.C. Temporal progression of kainic acid induced neuronal and myelin degeneration in the rat forebrain. Brain Res. 864 (2000) 69-80
14. Irwin I., Delanney L., Chan P., Sandy M.S., Di Monte D.A., and Langston J.W. Nigrostriatal monoamine oxidase A and B in aging squirrel monkeys and C57BL/6 mice. Neurobiol. Aging 18 (1997) 235-241
15. Irwin I., Finnegan K.T., Delanney L.E., Di Monte D., and Langston J.W. The relationships between aging, monoamine oxidase, striatal dopamine and the effects of MPTP in C57BL/6 mice: a critical reassessment. Brain Res. 572 (1992) 224-231
16. Kumar M.J., Nicholls D.G., and Andersen J.K. Oxidative α-ketoglutarate dehydrogenase inhibition via subtle elevations in monoamine oxidase B levels results in loss of spare respiratory capacity: implications for Parkinson's disease. J. Biol. Chem. 278 (2003) 46432-46439
17. Lang A.E., and Lozano A.M. Parkinson's disease. First of two parts. N. Engl. J. Med. 339 (1998) 1044-1053
18. Langston J.W., Ballard P., Tetrud J.W., and Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219 (1983) 979-980
19. Mori A., Ohashi S., Nakai M., Moriizumi T., and Mitsumoto Y. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice. Neurosci. Res. 51 (2005) 265-274
20. + in rat striatum. Brain Res. 828 (1999) 68-73
21. +). Neurosci. Lett. 85 (1988) 228-232
22. Ricaurte G.A., DeLanney L.E., Irwin I., and Langston J.W. Older dopaminergic neurons do not recover from the effects of MPTP. Neuropharmacology 26 (1987) 97-99
23. Sedelis M., Schwarting R.K., and Huston J.P. Behavioral phenotyping of the MPTP mouse model of Parkinson's disease. Behav. Brain Res. 125 (2001) 109-125
24. Song D.D., and Haber S.N. Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting. J. Neurosci. 20 (2000) 5102-5114
25. Sugama S., Yang L., Cho B.P., DeGiorgio L.A., Lorenzl S., Albers D.S., Beal M.F., Volpe B.T., and Joh T.H. Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice. Brain Res. 964 (2003) 288-294